Anzeige
Mehr »
Login
Donnerstag, 09.07.2020 Börsentäglich über 12.000 News von 632 internationalen Medien
Breaking News: Da raucht die Prozentanzeige des Börsentickers!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2ALP6 ISIN: US1850631045 Ticker-Symbol: CLM 
Frankfurt
08.07.20
08:03 Uhr
1,652 Euro
-0,008
-0,48 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
CLEARSIDE BIOMEDICAL INC Chart 1 Jahr
5-Tage-Chart
CLEARSIDE BIOMEDICAL INC 5-Tage-Chart
RealtimeGeldBriefZeit
1,5901,70007:30

Aktuelle News zur CLEARSIDE BIOMEDICAL Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
18.06.Clearside Biomedical, Inc. - 8-K, Current Report2
CLEARSIDE BIOMEDICAL Aktie jetzt für 0€ handeln
17.06.Clearside Biomedical, Inc.: Clearside Biomedical Announces Numerous Presentations at the ARVO 2020 Meeting2
22.05.BRIEF-Clearside Biomedical Files For Common Stock Offering Of Upto $50 Mln8
19.05.Clearside Bio files for $250M mixed shelf4
08.05.BRIEF-Clearside Biomedical Inc Files For Mixed Shelf Of Upto $250 Million - SEC Filing4
08.05.Clearside Biomedical, Inc. - 10-Q, Quaterly Report1
08.05.Clearside Biomedical EPS beats by $0.05, beats on revenue5
08.05.Clearside Biomedical, Inc. - 8-K, Current Report-
28.04.Clearside Bio down 9% on delay in refiling Xipere application3
28.04.BRIEF-Clearside Biomedical Revises NDA Resubmission Timeline And XIPERE Commercial Deal With Bausch Health13
28.04.Clearside Biomedical, Inc. - 8-K, Current Report-
22.04.Clearside Biomedical, Inc. - 8-K, Current Report1
09.04.Clearside Biomedical, Inc.: Clearside Biomedical Establishes Scientific Advisory Board with Distinguished Retinal Physicians2
08.04.Clearside Biomedical, Inc. - 8-K, Current Report1
17.03.Clearside Biomedical (CLSD) Investor Presentation - Slideshow8
16.03.Clearside Biomedical, Inc. - 8-K, Current Report2
12.03.Clearside Biomedical, Inc. (CLSD) CEO George Lasezkay on Q4 2019 Results - Earnings Call Transcript4
11.03.Clearside Biomedical, Inc.: Clearside Biomedical Announces Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update2
27.02.Clearside Biomedical, Inc.: Clearside Biomedical to Report Fourth Quarter and Full Year 2019 Financial Results and Provide Corporate Update on Wednesday, ...4
25.02.Clearside Biomedical, Inc.: Clearside Biomedical Pipeline Highlighted in Oral Presentations at the Annual Angiogenesis and Macula Society Meetings3
Seite:  Weiter >>
26 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1